GIORGIONI, Gianfabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.180
EU - Europa 4.913
AS - Asia 4.179
SA - Sud America 484
AF - Africa 189
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 13
Totale 19.987
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.836
CN - Cina 1.646
SG - Singapore 1.258
RU - Federazione Russa 1.212
IT - Italia 1.004
DE - Germania 662
BR - Brasile 403
VN - Vietnam 379
HK - Hong Kong 347
GB - Regno Unito 327
SE - Svezia 300
UA - Ucraina 293
CA - Canada 283
PL - Polonia 268
FR - Francia 259
FI - Finlandia 238
ZA - Sudafrica 141
TR - Turchia 118
KR - Corea 116
IE - Irlanda 85
IN - India 70
CZ - Repubblica Ceca 53
JP - Giappone 53
NL - Olanda 47
BE - Belgio 43
MX - Messico 43
BD - Bangladesh 34
ES - Italia 34
AR - Argentina 26
AU - Australia 26
IQ - Iraq 23
PK - Pakistan 20
UZ - Uzbekistan 17
EG - Egitto 15
HR - Croazia 14
IR - Iran 14
PE - Perù 14
AT - Austria 13
EU - Europa 13
EC - Ecuador 12
LT - Lituania 11
AE - Emirati Arabi Uniti 10
SA - Arabia Saudita 10
CH - Svizzera 9
MA - Marocco 9
AZ - Azerbaigian 8
CO - Colombia 8
UY - Uruguay 8
ID - Indonesia 7
KE - Kenya 7
PT - Portogallo 7
KG - Kirghizistan 6
TH - Thailandia 6
VE - Venezuela 6
DZ - Algeria 5
GR - Grecia 5
JO - Giordania 5
RO - Romania 5
BY - Bielorussia 4
CL - Cile 4
CR - Costa Rica 4
SY - Repubblica araba siriana 4
TN - Tunisia 4
BB - Barbados 3
BG - Bulgaria 3
GE - Georgia 3
HU - Ungheria 3
IL - Israele 3
MY - Malesia 3
NP - Nepal 3
PA - Panama 3
PH - Filippine 3
PS - Palestinian Territory 3
AL - Albania 2
DK - Danimarca 2
GT - Guatemala 2
KH - Cambogia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GH - Ghana 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
Totale 19.977
Salva come PNG Salva come JPEG
Città #
Ashburn 860
Fairfield 768
Woodbridge 755
Jacksonville 702
Singapore 701
San Jose 547
Chandler 534
Houston 448
Ann Arbor 445
Dallas 385
Wilmington 375
Hong Kong 340
Boardman 335
Seattle 323
Cambridge 287
Beijing 258
Nanjing 234
Camerino 203
Los Angeles 184
Toronto 178
Warsaw 171
Johannesburg 128
Ho Chi Minh City 126
New York 124
San Mateo 121
Helsinki 120
Seoul 113
Tongling 109
The Dalles 108
Dearborn 106
Lawrence 100
Princeton 100
Munich 95
Lauterbourg 92
Kraków 91
Istanbul 89
Columbus 85
Dublin 83
Nanchang 82
Ogden 82
Moscow 80
Hanoi 75
Buffalo 73
Shenyang 69
London 65
Lachine 63
Council Bluffs 59
Düsseldorf 58
Orem 57
Kunming 56
Santa Clara 56
Shanghai 56
Milan 55
Redwood City 50
Tokyo 49
Frankfurt am Main 44
Tianjin 43
Chicago 42
Hebei 42
Brussels 40
Brno 38
Guangzhou 32
Rome 31
São Paulo 31
Jiaxing 30
San Diego 30
Trieste 29
Changsha 27
Turku 27
Wuhan 27
Stockholm 26
Jinan 25
St Louis 25
Bremen 24
Brooklyn 24
Chennai 24
Poplar 24
Philadelphia 23
Atlanta 22
Augusta 22
Centro 22
Da Nang 22
Ascoli Piceno 21
Boston 21
Denver 21
Leawood 21
Hangzhou 20
Montreal 20
Ningbo 20
Venezia 19
Hefei 18
Zhengzhou 18
Redondo Beach 17
Venice 17
Auburn Hills 16
Haiphong 16
Nuremberg 16
Orange 15
Phoenix 15
Rio de Janeiro 15
Totale 13.030
Salva come PNG Salva come JPEG
Nome #
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 615
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 330
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 326
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 295
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: synthesis and affinity at 5-HT2A, 5-HT2B and 5-HT2c serotonin receptors 267
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 267
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 266
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 262
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 253
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 242
5HT2B receptor antagonists: a probe for spotting the pharmacophore 241
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 240
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 238
14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry 235
3-[2-[4-(4-Fluorobenzoyl)piperidin-1-yl]ethyl]-5,6,7,8-tetrahydro-4(3H)quinazolinones: serotonin 5-HT2A receptor antagonists endowed with potent, central action 231
Benzimidazole, benzoxazole and benzothiazole derivatives as 5HT(2B) receptor ligands. Synthesis and preliminary pharmacological evaluation 228
Evaluation of P(L)LA-PEG-P(L)LA as processing aid for biodegradable particles from gas saturated solutions (PGSS) process 224
Evaluation of methoxy polyethylene glycol-polylactide diblock copolymers as additive in hypromellose film coating 218
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 218
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 216
Dimeric L-Dopa Derivatives as Potential Prodrugs 216
Synthesis of Novel 4-Aryl-1,2,3,4-tetrahydroisoquinolines as Probes for Dopamine Receptor Ligands 213
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 213
Synthesis and pharmacological evaluation of 4-phenoxy-1,2,3,4-tetrahydroisoquinolines and 4,5,6,6a-tetrahydrochromeno [2,3,4-de]isoquinolines 212
Simplified analogues of Ritanserin and their affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors 212
Synthesis and Evaluation of 2-(5-Methoxythiophen-3- yl)ethylamines as Potential Dopamine Agonists 212
Synthesis and Preliminary Pharmacological Evaluation of 5-Hydroxy- and 5,6-Dihydroxy-1,2,3,7,12,12a-hexahydrobenzo [5,6]cyclohepta[1,2,3-ij]isoquinoline Derivatives as Dopamine Receptor Ligands 211
Monitoring the aggregation behaviour of self-assembling polymers through high-resolution ultrasonic spectroscopy, 210
New Flurbiprofen Derivatives: Synthesis, Membrane Affinity and Evaluation of in Vitro Effect on β-Amyloid Levels 210
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 210
New 2- pyridylethylamines with dopaminergic activity: synthesis and radioligand binding evaluation 209
Dopamine D-5 receptors: A challenge to medicinal chemists 208
4-(3-Piridil)-1,2,3,4-tetraidroisochinoline potenziali ligandi dei recettori della dopamina 206
Novel Imidazoline Compounds as Partial or Full Agonists of D2-Like Dopamine Receptors Inspired by I2-Imidazoline Binding Sites Ligand 2-BFI 206
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 205
Synthesis of L-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2,5-diketomorpholine as potential prodrug of L-Dopa 204
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 203
Synthesis and Pharmacological Characterization of 2-(4-Chloro-3-hydroxyphenyl)ethylamine and N,N-dialkyl Derivatives as Dopamine Receptor Ligands 203
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 202
Evaluation of polymer mucoadhesiveness by the use of acoustic spectroscopy 199
Thermosensitive self-assembling block copolymers as drug delivery systems 197
New Systems for the Specific Delivery and Sustained Release of Dopamine to the Brain 196
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 195
16th Camerino-Noordwijkerhout Symposium - An Overview of Receptor Chemistry 195
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 195
4WD to Travel Inside the 5-HT1A Receptor World 194
Novel Dopamine Receptor Ligands Bearing Imidazoline Nucleus. 188
New L-dopa codrugs as potential antiparkinson agents 187
Evaluation of 2,3,4,8,13a hexahydro-1H-benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 186
Glycosyl and polyalcoholic prodrugs of lonidamine. 185
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 184
Correlation among chemical structure, surface properties and cytotoxicity of N-acyl alanine and serine surfactants 183
trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: Synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D-1 receptor full agonist 180
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 180
Activity of N-(2-Phenylethyl)-N-n-Propyl-2-(3-Hydroxyphenyl)ethylamine Derivatives as Dopamine Receptor Ligands 178
Synthesis, resolution and preliminary evaluation of trans-2-amino-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes and related derivatives as dopamine receptor ligands 178
Chemical–physical properties and cytotoxicity of N-decanoyl amino acid-based surfactants: Effect of polar heads 177
Quaternary Ammonium Leucine-Based Surfactants: The Effect of a Benzyl Group on Physicochemical Properties and Antimicrobial Activity 177
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 176
Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats 175
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 173
Design, synthesis and preliminary pharmacological evaluation of new imidazolinonesas L-DOPA prodrugs 171
Synthesis and Biological Evaluation of GABA Derivatives Able to Cross the Blood -Brain Barrier in Rats 170
Quaternary ammonium surfactants derived from leucine and methionine: Novel challenging surface active molecules with antimicrobial activity 170
DISCOVERY OF NEW POTENTIAL gamma-SECRETASE MODULATORS FOR THE TREATMENT OF ALZHEIMER’S DISEASE 168
Receptors in aging diseases: Dopamine receptors 167
4-Aryloxy-1,2,3,4-tetrahydroisoquinolines as new potential antipsychotic drugs 166
Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior 164
A Comparative Behavioural Analysis in Rats of the D2 Agonist RU 24213 and Two New Structurally Similar Compounds 163
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands 161
Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3,12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinoles as dopamine receptor ligands 161
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor 160
Synthesis and Evaluation of N-n-Propyl-N-(2-phenylethyl)-2-(3-fluoro-4- hydroxyphenyl)ethylamine Derivatives as Dopamine Receptor Ligands 159
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders 157
A de novo design probe of a dopamine receptor ligand based on a theoretical approach 154
Imidazolidinoni profarmaci della L-DOPA 151
Synthesis and SAR of group 11 N-heterocyclic carbene complexes 149
Polyhydroxylic Prodrugs of Lonidamine 148
Toxicological profiles and surface properties at physiological pH of N-decanoyl amino acids 148
Preparation and Pharmacological Characterization of trans-2-Amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like Dopamine Receptor Agonists 145
Synthesis and Dopamine Receptor Binding of 4-(2-Aminoethyl)-1H-pyrazole and Its N,N- Dialkyl Derivatives 141
Structure-Activity Relationships of N-n-Propyl-2-(4-fluoro-3-hydroxyphenyl)ethylamine Derivatives as Dopamine Receptor Ligands 141
Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives 137
L-Dopa codrugs containing antioxidant molecules as potential antiparkinson agents 134
Choline pivaloyl esters improve in rats cognitive and memory performances impaired by scopolamine treatment or cognitive and memory performances impaired by scopolamine treatment orlesions of the nucleus basalis of Meynert 129
Novel antitumor Cu(I) and Cu(II) complexes based on bioconjugate ligands rationally designed to act through synergistic mechanisms 128
Investigating the role of the central melanocortin system in stress and stress-related disorders 121
Receptors in aging disease 121
Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma 119
New anticancer copper complexes containing ligands conjugated with biologically active molecules 119
Copper complexes with adamantane ring-conjugated ligands as promising agents for the treatment of glioblastoma 118
ANTIDEPRESSANT-LIKE ACTIVITY OF NOVEL IMIDAZOLINE LIGANDS DIRECTED TO THE SEROTONIN 5-HT1A RECEPTOR 116
Effect on binge eating episode in female rats of a potent 1 antagonist analogue of spipethiane 115
Highly Potent and Selective Dopamine D4 Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma 115
IBUPROFEN AND LIPOIC ACID DIAMIDE AS CO-DRUGS WITH NEUROPROTECTIVE ACTIVITY: PHARMACOLOGICAL PROPERTIES AND EFFECTS IN Βeta-AMYLOID (1-40) INFUSED ALZHEIMER’S DISEASE RAT MODEL 113
Medicinal chemistry and pharmacology of purinergic receptors 113
New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma 113
Trends in drug Research 108
Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma 107
Novel Potent Muscarinic Receptor Antagonists: Investigation on the Nature of Lipophilic Substituents in the 5- and/or 6-Positions of the 1,4-Dioxane Nucleus 105
Totale 18.900
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.889
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021647 0 0 0 0 0 0 0 0 0 95 380 172
2021/20221.052 83 262 18 51 84 57 35 73 86 117 56 130
2022/20231.484 180 49 75 194 163 201 17 90 264 79 122 50
2023/20241.084 127 61 100 34 39 93 57 36 118 35 24 360
2024/20253.783 167 90 321 165 87 204 457 911 293 238 245 605
2025/20265.251 345 344 695 848 562 426 905 422 337 367 0 0
Totale 20.244